본문 바로가기

Structural and energetic insights into SARS-CoV-2 nucleocapsid protein inhibitors from molecular dynamics and MM-PBSA analyses

문서 유형
연구출판물 · 학술지 논문
등재
KCISCIEScopus
저널 순위
JCR Q3Scopus Q2KCI Q2
저널
Bulletin of the Korean Chemical Society47(9) · pp.1162 · 2026
피인용
Web of Science 0Scopus 0KCI 0
FWCI (Scopus)
0
JCR IF
JCR 2024 2.2
ISSN
0253-2964

저자

  1. 치투말라 스리마이제1저자Pusan Natl Univ, Dept Nanofus Technol, Busan 46241, South Korea
  2. 김재영Pusan Natl Univ, Dept Nanofus Technol, Busan 46241, South Korea
  3. Zhao, Mengdi교신저자Suzhou Univ Sci & Technol, Dept Mat Sci & Engn, Suzhou 215009, Peoples R China
  4. 장준경교신저자Pusan Natl Univ, Dept Nanofus Technol, Busan 46241, South Korea

초록

The SARS-CoV-2 nucleocapsid (N) protein is a key regulator of viral genome packaging and replication, making it an attractive antiviral target. Here, we provide structural and energetic insights into N-protein inhibition using molecular docking, pharmacophore screening, molecular dynamics (MD) simulations, and MM-PBSA analyses. Experimentally known inhibitors Onalespib, JQ-1, and Zotatifin were used to construct pharmacophores that screened the ZINC database, yielding 927 hits. Three top candidates, ZINC37602048, ZINC06246181, and ZINC12077824, underwent 150 ns MD simulations to assess their long-term dynamic stability within the N-protein binding pocket. MM-PBSA calculations over the 150 ns trajectories revealed strong binding for ZINC37602048 (−27.24 kcal/mol) and ZINC06246181 (−22.81 kcal/mol), driven mainly by van der Waals contributions, whereas ZINC12077824 showed comparatively weaker, though still favorable, affinity (−18.91 kcal/mol) owing to a large unfavorable electrostatic contribution partially offset by polar solvation. These results highlight promising scaffolds for further optimization and underscore the utility of MD and free energy-based methods in guiding antiviral drug discovery targeting the SARS-CoV-2 N protein.

키워드

MM-PBSAmolecular dynamicsN-proteinpharmacophore modelingSARS-CoV-2 inhibitors

식별자

Scopus EID
2-s2.0-105047732598
WoS UID
001851718900001
KCI
ART003389537